Symphony Financial, Ltd. Co. Merck & Co., Inc. Transaction History

Symphony Financial, Ltd. Co.

$608 Million
Q3 2024

A detailed history of Symphony Financial, Ltd. Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 10,888 shares of MRK stock, worth $1.11 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,888

Previous 9,811 10.98%

Holding current value

$1.11 Million

Previous $1.21 Million 1.81%

% of portfolio

0.2%

Previous 0.22%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$111.15 - $128.97 $119,708 - $138,900	1,077 Added 10.98%	10,888 $1.24 Million
Q2 2024 Jul 17, 2024	BUY	$123.8 - $132.96 $113,400 - $121,791	916 Added 10.3%	9,811 $1.21 Million
Q1 2024 Apr 17, 2024	BUY	$113.24 - $131.95 $75,984 - $88,538	671 Added 8.16%	8,895 $1.17 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $36,465 - $39,683	364 Added 4.63%	8,224 $896,000
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $55,181 - $61,280	-536 Reduced 6.38%	7,860 $809,000
Q2 2023 Jul 12, 2023	SELL	$108.61 - $118.38 $94,490 - $102,990	-870 Reduced 9.39%	8,396 $968,000
Q1 2023 May 03, 2023	BUY	$102.94 - $114.86 $344,951 - $384,895	3,351 Added 56.65%	9,266 $985,000
Q4 2022 Jan 26, 2023	BUY	$87.44 - $112.11 $27,805 - $35,650	318 Added 5.68%	5,915 $0
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $45,899 - $51,563	543 Added 10.74%	5,597 $485,000
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $54,185 - $61,421	649 Added 14.73%	5,054 $468,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $85,639 - $95,996	1,165 Added 35.96%	4,405 $382,000
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $234,187 - $293,349	3,240 New	3,240 $249,000
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $212,817 - $234,046	-2,969 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$70.31 - $77.77 $89,082 - $98,534	-1,267 Reduced 29.91%	2,969 $232,000
Q1 2021 Apr 15, 2021	SELL	$68.86 - $81.11 $107,628 - $126,774	-1,563 Reduced 26.95%	4,236 $321,000
Q4 2020 Jan 13, 2021	SELL	$71.77 - $79.65 $11,842 - $13,142	-165 Reduced 2.77%	5,799 $470,000
Q3 2020 Oct 09, 2020	BUY	$73.18 - $82.95 $17,124 - $19,410	234 Added 4.08%	5,964 $495,000
Q2 2020 Jul 08, 2020	BUY	$70.42 - $80.13 $124,572 - $141,749	1,769 Added 44.66%	5,730 $443,000
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $250,968 - $347,855	3,961 New	3,961 $305,000

Others Institutions Holding MRK

# of Institutions

3,808

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.

Account

Symphony Financial, Ltd. Co. Merck & Co., Inc. Transaction History